Insider Trading activities of Nps Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nps Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nps Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Nps Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is NPSP. The reporting company's CIK number is 890465.
The total value of stock buying since 2005 is $2,667,940.
The total value of stock sales since 2005 is $46,204,505.
The total value of stock option exercises since 2005 is $10,604,627.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Nps Pharmaceuticals Inc (NPSP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-02 0 $0 39,333 $1,805,084 176,109 $1,621,677
2014-12 0 $0 95,590 $3,332,619 93,090 $516,921
2014-11 0 $0 101,047 $3,076,689 85,859 $414,563
2014-10 0 $0 40,635 $1,109,608 0 $0
2014-08 0 $0 0 $0 55,480 $247,270
2014-06 0 $0 0 $0 5,788 $0
2014-02 0 $0 12,188 $459,487 144,386 $0
2014-01 0 $0 31,588 $1,105,895 31,588 $105,503
2013-12 0 $0 321,172 $8,199,778 460,288 $2,523,594
2013-09 0 $0 318,770 $10,048,562 189,112 $1,067,893
2013-08 0 $0 126,900 $3,162,125 120,000 $686,670
2013-05 0 $0 45,150 $640,001 45,150 $182,857
2013-04 0 $0 551,232 $6,293,403 531,850 $2,194,242
2013-02 0 $0 28,175 $246,248 110,500 $0
2012-11 11,000 $99,990 0 $0 0 $0
2012-10 0 $0 140,625 $1,337,062 140,625 $840,937
2011-11 70,000 $376,000 0 $0 0 $0
2011-01 0 $0 50,000 $500,000 50,000 $202,500
2010-02 0 $0 19,350 $65,209 0 $0
2009-10 0 $0 0 $0 21,533 $0
2008-09 0 $0 474,800 $4,107,217 0 $0
2008-04 0 $0 0 $0 21,534 $0
2008-03 413,500 $1,559,202 0 $0 0 $0
2007-11 0 $0 0 $0 45,000 $0
2007-05 0 $0 38,100 $154,914 0 $0
2006-05 9,620 $50,024 0 $0 0 $0
2005-12 0 $0 3,000 $37,110 0 $0
2005-08 10,000 $96,500 0 $0 0 $0
2005-07 0 $0 1,000 $10,870 0 $0
2005-06 8,500 $92,539 0 $0 0 $0
2005-05 4,000 $51,800 40,297 $512,624 0 $0
2005-03 30,500 $341,885 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Nps Pharmaceuticals Inc insiders (NPSP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-02-17 Beshar Luke M (EVP & CFO) Option Ex 7,422 18.24 135,399
2015-02-13 Garceau Roger (SVP & CMO) Option Ex 10,531 .00 0
2015-02-13 Nader Francois (President, CEO and Director) Option Ex 24,301 .00 0
2015-02-13 Pauwels Eric (President, NPS Pharma Int'l) Option Ex 8,100 .00 0
2015-02-13 Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) Option Ex 3,240 .00 0
2015-02-13 Beshar Luke M (EVP & CFO) Option Ex 10,531 .00 0
2015-02-12 Graf Susan E (VP,Corp Development & Strategy) Option Ex 1,445 .00 0
2015-02-12 Garceau Roger (SVP & CMO) Option Ex 3,832 .00 0
2015-02-12 Nader Francois (President, CEO and Director) Option Ex 43,804 10.61 464,935
2015-02-12 Pauwels Eric (President, NPS Pharma Int'l) Option Ex 2,787 .00 0
2015-02-12 Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) Option Ex 1,567 .00 0
2015-02-12 Beshar Luke M (EVP & CFO) Option Ex 3,832 .00 0
2015-02-10 Graf Susan E (VP, Corp Development & Strateg) Sale 6,711 45.87 307,833
2015-02-10 Graf Susan E (VP, Corp Development & Strateg) Option Ex 6,711 14.90 99,993
2015-02-05 Garceau Roger (SVP & CMO) Option Ex 15,384 45.88 705,817
2015-02-05 Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) Sale 32,622 45.90 1,497,251
2015-02-05 Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) Option Ex 32,622 6.61 215,533
2014-12-17 Selisker Rachel R (Director) Sale 3,708 34.59 128,259
2014-12-17 Selisker Rachel R (Director) Option Ex 1,208 4.24 5,121
2014-12-17 Rogus Joseph J (SVP Gbl Tech Oper Sup Chn Mgt) Sale 16,467 35.00 576,345
2014-12-17 Rogus Joseph J (SVP Gbl Tech Oper Sup Chn Mgt) Option Ex 16,467 4.20 69,079
2014-12-17 Beshar Luke M (EVP & CFO) Sale 52,258 35.00 1,829,030
2014-12-17 Beshar Luke M (EVP & CFO) Option Ex 52,258 6.59 344,536
2014-12-08 Selisker Rachel R (Director) Sale 23,157 34.50 798,985
2014-12-08 Selisker Rachel R (Director) Option Ex 23,157 4.24 98,185
2014-11-28 Selisker Rachel R (Director) Sale 11,635 34.50 401,419
2014-11-28 Selisker Rachel R (Director) Option Ex 11,635 4.24 49,332
2014-11-17 Rogus Joseph J (SVP, Gbl Technical Operations) Sale 26,782 30.00 803,540
2014-11-17 Rogus Joseph J (SVP, Gbl Technical Operations) Option Ex 26,782 3.34 89,451
2014-11-17 Beshar Luke M (EVP & CFO) Sale 47,442 30.01 1,423,639
2014-11-17 Beshar Luke M (EVP & CFO) Option Ex 47,442 5.81 275,780
2014-11-11 Selisker Rachel R (Director) Sale 15,188 29.50 448,091
2014-10-31 Beshar Luke M (EVP & CFO) Sale 10,000 29.00 290,000
2014-10-27 Beshar Luke M (EVP & CFO) Sale 30,635 26.75 819,608
2014-08-13 Beshar Luke M (EVP & CFO) Option Ex 53,813 4.60 247,270
2014-08-01 Pauwels Eric (President, NPS Pharma Int'l) Option Ex 1,667 .00 0
2014-06-17 Graf Susan E (VP,Corp Development & Strategy) Option Ex 5,788 .00 0
2014-02-13 Stratemeier Ed (SVP & General Counsel) Option Ex 5,670 .00 0
2014-02-13 Garceau Roger (SVP & CMO) Option Ex 10,530 .00 0
2014-02-13 Nader Francois (President, CEO and Director) Option Ex 24,301 .00 0
2014-02-13 Melrose Glenn R (SVP, Human Resources) Option Ex 6,075 .00 0
2014-02-13 Pauwels Eric (SVP & Chief Commercial Officer) Option Ex 8,100 .00 0
2014-02-13 Selisker Rachel R (Director) Option Ex 15,188 .00 0
2014-02-13 Rogus Joseph J (VP, Technical Operations) Option Ex 3,240 .00 0
2014-02-13 Broom Colin Md (Director) Option Ex 15,188 .00 0
2014-02-13 Gemayel Georges (Director) Sale 6,188 37.70 233,287
2014-02-13 Gemayel Georges (Director) Option Ex 15,188 .00 0
2014-02-13 Granadillo Pedro P (Director) Option Ex 15,188 .00 0
2014-02-13 Beshar Luke M (EVP & CFO) Option Ex 10,530 .00 0
2014-02-13 Groninger James G (Director) Sale 6,000 37.70 226,200
2014-02-13 Groninger James G (Director) Option Ex 15,188 .00 0
2014-01-08 Beshar Luke M (EVP & CFO) Sale 31,588 35.01 1,105,895
2014-01-08 Beshar Luke M (EVP & CFO) Option Ex 31,588 3.34 105,503
2013-12-26 Beshar Luke M (EVP & CFO) Sale 37,874 30.02 1,136,977
2013-12-26 Beshar Luke M (EVP & CFO) Option Ex 37,874 4.52 171,379
2013-12-23 Groninger James G (Director) Sale 3,000 29.50 88,500
2013-12-23 Groninger James G (Director) Option Ex 3,000 21.73 65,190
2013-12-18 Stratemeier Ed (SVP & General Counsel) Sale 154,460 25.17 3,887,758
2013-12-18 Stratemeier Ed (SVP & General Counsel) Option Ex 154,460 5.91 913,167
2013-12-17 Stratemeier Ed (SVP & General Counsel) Sale 50,972 25.00 1,274,300
2013-12-17 Stratemeier Ed (SVP & General Counsel) Option Ex 50,972 3.60 183,499
2013-12-16 Stratemeier Ed (SVP & General Counsel) Sale 14,555 25.00 363,875
2013-12-16 Stratemeier Ed (SVP & General Counsel) Option Ex 14,555 3.60 52,398
2013-12-12 Nader Francois (President, CEO and Director) Option Ex 139,116 4.61 641,602
2013-12-12 Beshar Luke M (EVP & CFO) Sale 60,311 24.02 1,448,368
2013-12-12 Beshar Luke M (EVP & CFO) Option Ex 60,311 8.23 496,359
2013-09-27 Nader Francois (President, CEO and Director) Sale 43,458 32.36 1,406,127
2013-09-27 Nader Francois (President, CEO and Director) Option Ex 43,458 5.91 256,706
2013-09-26 Nader Francois (President, CEO and Director) Sale 150,000 33.34 5,000,250
2013-09-26 Nader Francois (President, CEO and Director) Option Ex 20,342 5.45 110,863
2013-09-20 Beshar Luke M (EVP & CFO) Sale 50,000 30.24 1,511,850
2013-09-20 Beshar Luke M (EVP & CFO) Option Ex 50,000 5.78 289,000
2013-09-16 Rogus Joseph J (VP, Technical Operations) Sale 25,312 28.32 716,835
2013-09-16 Rogus Joseph J (VP, Technical Operations) Option Ex 25,312 8.25 208,824
2013-09-16 Beshar Luke M (EVP & CFO) Sale 50,000 28.27 1,413,500
2013-09-16 Beshar Luke M (EVP & CFO) Option Ex 50,000 4.05 202,500
2013-08-30 Garceau Roger (SVP & CMO) Sale 110,000 25.18 2,769,910
2013-08-30 Garceau Roger (SVP & CMO) Option Ex 110,000 5.86 644,270
2013-08-20 Groninger James G (Director) Sale 16,900 23.21 392,215
2013-08-20 Groninger James G (Director) Option Ex 10,000 4.24 42,400
2013-05-09 Beshar Luke M (EVP & CFO) Sale 45,150 14.18 640,001
2013-05-09 Beshar Luke M (EVP & CFO) Option Ex 45,150 4.05 182,857
2013-04-29 Beshar Luke M (EVP & CFO) Sale 4,850 14.00 67,900
2013-04-29 Beshar Luke M (EVP & CFO) Option Ex 4,850 4.05 19,642
2013-04-10 Nader Francois (President, CEO and Director) Sale 148,367 11.68 1,732,481
2013-04-10 Nader Francois (President, CEO and Director) Option Ex 128,985 3.60 463,959
2013-04-10 Beshar Luke M (EVP & CFO) Sale 50,000 12.00 600,200
2013-04-10 Beshar Luke M (EVP & CFO) Option Ex 50,000 4.05 202,500
2013-04-09 Nader Francois (President, CEO and Director) Sale 150,000 11.27 1,689,900
2013-04-09 Nader Francois (President, CEO and Director) Option Ex 150,000 4.04 606,450
2013-04-09 Rogus Joseph J (VP, Technical Operations) Sale 48,015 11.50 552,172
2013-04-09 Rogus Joseph J (VP, Technical Operations) Option Ex 48,015 4.79 229,991
2013-04-08 Nader Francois (President, CEO and Director) Sale 150,000 11.00 1,650,750
2013-04-08 Nader Francois (President, CEO and Director) Option Ex 150,000 4.48 671,700
2013-02-19 Garceau Roger (EVP & CMO) Option Ex 27,500 .00 0
2013-02-19 Nader Francois (President & CEO) Option Ex 50,000 .00 0
2013-02-19 Rogus Joseph J (VP, Technical Operations) Option Ex 13,000 .00 0
2013-02-19 Beshar Luke M (EVP & CFO) Option Ex 20,000 .00 0
2013-02-07 Selisker Rachel R (Director) Sale 5,325 8.74 46,540
2013-02-07 Broom Colin Md (Director) Sale 6,100 8.74 53,314
2013-02-07 Bonney Michael W (Director) Sale 5,325 8.74 46,540
2013-02-07 Groninger James G (Director) Sale 5,325 8.74 46,540
2013-02-07 Tombros Peter G (Director) Sale 6,100 8.74 53,314
2012-11-15 Melrose Glenn R (SVP, Human Resources) Buy 11,000 9.09 99,990
2012-10-03 Garceau Roger (SVP & CMO) Sale 140,625 9.51 1,337,062
2012-10-03 Garceau Roger (SVP & CMO) Option Ex 140,625 5.98 840,937
2011-11-10 Stratemeier Ed (SVP & Acting GC) Buy 20,000 5.40 108,000
2011-11-09 Nader Francois (President, CEO and Director) Buy 30,000 5.36 160,800
2011-11-09 Beshar Luke M (SVP & CFO) Buy 20,000 5.36 107,200
2011-01-31 Beshar Luke M (SVP &CFO) Sale 50,000 10.00 500,000
2011-01-31 Beshar Luke M (SVP &CFO) Option Ex 50,000 4.05 202,500
2010-02-03 Nader Francois (President, CEO and Director) Sale 19,350 3.37 65,209
2009-10-17 Nader Francois (President & CEO) Option Ex 21,533 .00 0
2008-09-22 Bvf Inc/il (Other) Sale 283,200 8.72 2,468,654
2008-09-19 Bvf Inc/il (Other) Sale 191,600 8.55 1,638,563
2008-04-17 Nader Francois (President & CEO) Option Ex 21,534 .00 0
2008-03-19 Bvf Inc/il (Other) Buy 3,400 3.90 13,260
2008-03-17 Bvf Inc/il (Other) Buy 45,500 3.80 172,900
2008-03-12 Bvf Inc/il (Other) Buy 38,600 3.82 147,452
2008-03-11 Bvf Inc/il (Other) Buy 53,900 3.71 200,184
2008-03-10 Bvf Inc/il (Other) Buy 126,000 3.72 469,350
2008-03-07 Bvf Inc/il (Other) Buy 146,100 3.81 556,056
2007-11-02 Coles N Anthony (President, COO & Director) Option Ex 45,000 .00 0
2007-05-23 Klein Joseph Iii (Other) Sale 38,100 4.07 154,914
2006-05-10 Lasowski Juergen (Senior VP Business Development) Buy 9,620 5.20 50,024
2005-12-09 Kuhla Donald E (Executive Vice Presi) Sale 3,000 12.37 37,110
2005-08-24 Antczak Val R (Snr. V.P., General C) Buy 10,000 9.65 96,500
2005-07-28 Groninger James G (Director) Sale 1,000 10.87 10,870
2005-06-08 Antczak Val R (Snr. V.P., General C) Buy 8,500 10.89 92,539
2005-05-23 Groninger James G (Director) Sale 2,350 12.74 29,939
2005-05-17 Bonney Michael W (Director) Buy 4,000 12.95 51,800
2005-05-16 Marriott Thomas B Iii (VP, Development Rese) Sale 25,298 12.72 321,790
2005-03-11 Clark David L (VP, Corporate Affair) Buy 5,500 10.97 60,335
2005-03-11 Klein Joseph Iii (Director) Buy 25,000 11.26 281,550

Insider trading activities including stock purchases, stock sales, and option exercises of NPSP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nps Pharmaceuticals Inc (symbol NPSP, CIK number 890465) see the Securities and Exchange Commission (SEC) website.